Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hatherill

Showing results (141-150 of 222) with videos related to

Pageof 23
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 1, 2017
Differential Recognition of Mycobacterium tuberculosis-Specific Epitopes as a Function of Tuberculosis Disease HistoryThomas J Scriba, Chelsea Carpenter, Sebastian Carrasco Pro, et al.
Plos One|May 3, 2022
Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisitionRachel A Bender Ignacio, Jessica Long, Aparajita Saha, et al.
Vaccine|April 12, 2015
A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringeHennie D Geldenhuys, Helen Mearns, Jennifer Foster, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 7, 2023
Qualification of the differential leukocyte count and immunophenotyping in cryopreserved ex vivo whole blood assayClaire Imbratta, Anele Gela, Nicole Bilek, et al.
The New England Journal of Medicine|May 7, 2025
BCG Revaccination for the Prevention of <i>Mycobacterium tuberculosis</i> InfectionAlexander C Schmidt, Lee Fairlie, Elizabeth Hellström, et al.
Tuberculosis (Edinburgh, Scotland)|February 16, 2013
Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCGMichele Tameris, Helen McShane, J Bruce McClain, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Risk of progression to pulmonary tuberculosis among household contacts with chest radiographic abnormalities in South AfricaHumphrey Mulenga, Evans Muchiri, Simon C Mendelsohn, et al.
Plos One|September 9, 2017
Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden populationRichard Baguma, Adam Penn-Nicholson, Erica Smit, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2017
A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin-Specific Immune Responses and TuberculosisJaveed A Shah, Munyaradzi Musvosvi, Muki Shey, et al.
The Lancet. Global Health|June 8, 2026
Inclusion of young adolescents in policy development for new tuberculosis vaccinesMark Hatherill, Rebecca A Clark, Leonardo Martinez, et al.
Pageof 23

Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
American Journal of Respiratory and Critical Care Medicine|August 1, 2017
Differential Recognition of Mycobacterium tuberculosis-Specific Epitopes as a Function of Tuberculosis Disease HistoryThomas J Scriba, Chelsea Carpenter, Sebastian Carrasco Pro, et al.
Plos One|May 3, 2022
Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisitionRachel A Bender Ignacio, Jessica Long, Aparajita Saha, et al.
Vaccine|April 12, 2015
A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringeHennie D Geldenhuys, Helen Mearns, Jennifer Foster, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 7, 2023
Qualification of the differential leukocyte count and immunophenotyping in cryopreserved ex vivo whole blood assayClaire Imbratta, Anele Gela, Nicole Bilek, et al.
The New England Journal of Medicine|May 7, 2025
BCG Revaccination for the Prevention of <i>Mycobacterium tuberculosis</i> InfectionAlexander C Schmidt, Lee Fairlie, Elizabeth Hellström, et al.
Tuberculosis (Edinburgh, Scotland)|February 16, 2013
Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCGMichele Tameris, Helen McShane, J Bruce McClain, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Risk of progression to pulmonary tuberculosis among household contacts with chest radiographic abnormalities in South AfricaHumphrey Mulenga, Evans Muchiri, Simon C Mendelsohn, et al.
Plos One|September 9, 2017
Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden populationRichard Baguma, Adam Penn-Nicholson, Erica Smit, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2017
A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin-Specific Immune Responses and TuberculosisJaveed A Shah, Munyaradzi Musvosvi, Muki Shey, et al.
The Lancet. Global Health|June 8, 2026
Inclusion of young adolescents in policy development for new tuberculosis vaccinesMark Hatherill, Rebecca A Clark, Leonardo Martinez, et al.
Pageof 23